Knight Therapeutics Stock
Your prediction
Knight Therapeutics Stock
Pros and Cons of Knight Therapeutics in the next few years
Pros
Cons
Performance of Knight Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Knight Therapeutics | 0.000% | -2.985% | 8.939% | 6.557% | 4.839% | 11.429% | 16.766% |
| MicroPlanet Technology Corp | 0.000% | 0.746% | -8.163% | 42.405% | -11.184% | -15.625% | -32.161% |
| Biomark Diagnostics Inc. | 1.280% | -3.067% | 10.490% | 139.394% | 14.493% | 132.353% | 139.394% |
| Avricore Health Inc. | 1.230% | -6.818% | 1.235% | 70.833% | 78.261% | -81.696% | -82.174% |
News
EVP of North America's Largest Full Truckload Company EVP Sells All Insider Shares
Michael K Liu, EVP - Operations at Knight-Swift (NYSE:KNX), disposed of 1,243 directly held shares in an open-market sale on Feb. 4, 2026, fully exiting his direct equity position according to a SEC
Changing Your Dog's Diet May Help the Planet More Than Changing Your Own, Study Finds
LONDON, UK / ACCESS Newswire / February 10, 2026 / Diets high in meat, eggs, and dairy products incur significant environmental costs. But a new study has revealed that, in many cases,
One Fund Just Sold $23 Million of This Major Freight Stock. Here's What Investors Should Know
On February 4, Triton Wealth Management, PLLC reported selling 481,779 shares of Knight-Swift Transportation Holdings (NYSE:KNX), an estimated $22.58 million trade based on quarterly average


